The outlook is starting to look bright for biotech stocks, according to some. With markets now expecting the first rate cut to be in September rather than June or July, …
Small-cap stocks were on investors’ radar last week. The Russell 2000 index turned in five straight days of gains for the first time since mid-July, according to CNBC analysis. And …
It’s time to buy shares of Ionis Pharmaceuticals , according to Citi. The firm upgraded the stock on Monday to buy from neutral and raised its price target to $60 …